CANADIAN CANCER SOCIETY / Société canadienne du cancer
Registration:
32
of
91
(2013-11-15
to
2014-05-10)
Grant, Contribution or Other Financial Benefit
- Palliative and end-of-life care funding to enhance the access and availability of palliative care
Legislative Proposal, Bill or Resolution
- C-523, An Act to amend the Department of Health Act (disclosure of drug shortages), as it relates to notification requirements, public disclosure of notifications, and the legal definition of an interruption to the drug supply
- Hazardous Products Act, as it relates to the domestic use of asbestos
- Income Tax Act, as it relates to the taxation of tobacco companies
- Non-Smokers' Health Act, including implementation and enforcement
- Patent Act, as it relates to the use of patents for international humanitarian purposes to address public health problems
Legislative Proposal, Bill or Resolution, Regulation
- Canada Health Act and regulations, as it relates to recognizing home and palliative care as medically necessary
- Excise Act, 2001 and regulations, as it relates to contraband and the taxation of tobacco products
- First Nations Goods and Services Tax Act and regulations, as it relates to the taxation of tobacco products
- Food and Drugs Act and regulations, as it relates to nicotine replacement products
- Tobacco Act and regulations, including ingredients, packaging/labelling and enforcement
Policies or Program
- Canadian Partnership Against Cancer, as it relates to continued federal funding
- Compassionate Care Benefit Program under Employment Insurance, asking the federal governmnet to improve this benefit by increasing the number of weeks
- Framework Convention on Tobacco Control, including protocols, guidelines and implementation
- Health Canada's tobacco control program, including sustaining government funding levels, and implementation of effective programs and policies
- Rotterdam Convention, as it relates to the export of asbestos and the creation of a national disease registry and building registry
- UN Declaration on the Prevention and Control of Non-Communicable Diseases, as it pertains to cancer control, including the development of a Global Coordination Mechanism; increased federal investments in prevention initiatives; and policy changes as it relates to tobacco control, healthy living, and access to screening and treatment, as identified in the Declaration
Regulation
- Controlled Products Regulations, as it relates to implementing the Globally Harmonized System in Canada